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Abstract
Parkinson’s disease (PD) is characterized by the gradual degeneration of dopaminergic neurons in the substantia
nigra, leading to striatal dopamine depletion. A partial unilateral striatal 6-hydroxydopamine (6-OHDA) lesion
causes 40–60% dopamine depletion in the lesioned rat striatum, modeling the early stage of PD. In this study,
we explored the connectivity between the brain regions in partially 6-OHDA lesioned male Wistar rats under
urethane anesthesia using functional magnetic resonance imaging (fMRI) at 5 weeks after the 6-OHDA infusion.
Under urethane anesthesia, the brain fluctuates between the two states, resembling rapid eye movement (REM)
and non-REM sleep states. We observed clear urethane-induced sleep-like states in 8/19 lesioned animals and
8/18 control animals. 6-OHDA lesioned animals exhibited significantly lower functional connectivity between the
brain regions. However, we observed these differences only during the REM-like sleep state, suggesting the
involvement of the nigrostriatal dopaminergic pathway in REM sleep regulation. Corticocortical and corticostriatal
connections were decreased in both hemispheres, reflecting the global effect of the lesion. Overall, this study
describes a promising model to study PD-related sleep disorders in rats using fMRI.
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Significance Statement
Disturbances in sleep patterns and rapid eye movement (REM) sleep behavior disorder are among the first
symptoms of Parkinson’s disease (PD). However, PD-related sleep disorders have been virtually unexplored
in animal models. This is a first study which has examined the functional connectivity (FC) during
urethane-induced sleep-like states in the partial striatal 6-OHDA lesion rat model of early-stage PD using
functional magnetic resonance imaging (fMRI). We found that FC is significantly decreased in 6-OHDA
lesioned animals, but only during the REM-like state. These changes affected both the lesioned and intact
hemispheres, mostly involving corticocortical and corticostriatal connections. The results suggest that this
rat model is a promising tool for studying sleep disturbances in early-stage PD with resting-state fMRI.
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Introduction
Parkinson’s disease (PD) is the second most common
neurodegenerative disease and the most common move-
ment disorder affecting 1% of the population worldwide
after the age of 70 years (Pringsheim et al., 2014). A
gradual degeneration and loss of dopaminergic neurons
in the midbrain substantia nigra pars compacta are the
pathologic hallmarks leading to striatal dopamine (DA)
depletion, resulting in progressive motor symptoms in-
cluding bradykinesia, rigidity, and resting tremor, which
are characteristic of PD (Schapira, 2009). In addition to
the motor symptoms, PD patients suffer from a variety of
non-motor symptoms, including sleep disorders, olfactory
dysfunction, pain, depression, anxiety, impulsive behav-
ior, and cognitive impairment, which significantly impact
negatively on the patient’s quality of life (Titova and
Chaudhuri, 2017).
PD patients may experience a variety of sleep disorders,
such as restless legs syndrome, rapid eye movement (REM)
sleep behavior disorder (RBD), sleep fragmentation, and
insomnia (French and Muthusamy, 2016). Because sleep
disorders appear several years before the appearance of
the motor deficits (Bargiotas et al., 2016), they have been
considered as an early marker for PD. In particular, the
presence of RBD represents a considerably elevated risk
of developing PD (Postuma et al., 2013). PD patients with
RBD have increased -synuclein deposition (Postuma
et al., 2015), more severe initial motor symptoms, and
they require higher levodopa doses as the disease pro-
gresses (Chung et al., 2017). It is notable that alterations
in brain network organizations have been associated with
RBD even before the onset of obvious motor impairment
in PD (Ellmore et al., 2013). Thus, an experimental model
mimicking early sleep disorders is needed in assessing
potential treatments for these disorders and it may also
represent a new approach for testing novel disease-
modifying treatments for early-stage PD.
Unilateral lesioning of the substantia nigra dopaminer-
gic neurons using the 6-hydroxydopamine (6-OHDA) is
one of the most widely used animal models of PD (Bové
and Perier, 2012). This lesion induces a gradual degener-
ation of nigrostriatal DA neurons and motor impairments
resembling PD phenotypes. Depending on the adminis-
tration protocol and infusion site of the toxin, a 6-OHDA
lesion can produce very different degree of biochemical
and behavioral outcomes. A near complete loss of striatal
DA can be induced by infusing the toxin into the medial
forebrain bundle (MFB) or directly into the substantia nigra
(Lee et al., 1996; Yuan et al., 2005). This procedure leads
to prominent neurodegeneration and severe motor defi-
cits. Instead, an intrastriatal infusion of 6-OHDA produces
a partial striatal DA depletion (usually a 20–80% DA
deficiency depending on the 6-OHDA dose and number of
infusion sites) accompanied by mild but progressive well
characterized motor deficits (Sauer and Oertel, 1994; Pr-
zedbroski et al., 1995; Leikas et al., 2017). Thus, this
partial 6-OHDA lesion is considered more relevant as a
model for early-stage PD. Despite the relevance of sleep
disturbances in early PD, the effects of the partial striatal
6-OHDA lesion on brain connectivity and sleep have not
been well characterized. For example, it is not known
whether the 6-OHDA lesioned rats express disturbances
in brain activity during sleep resembling those encoun-
tered in PD patients.
Resting-state functional magnetic resonance imaging
(rsfMRI) is a sophisticated MRI technique assessing func-
tional connectivity (FC). It is typically based on the detec-
tion of correlating spontaneous low-frequency (0.1 Hz)
fluctuations in blood oxygenation level-dependent (BOLD)
signals (Biswal et al., 1995); similar BOLD signal fluctua-
tion profiles in different brain regions reflect synchronized
neuronal activity and FC. It has proven its clinical value as
a non-invasive imaging method for assessing disruptions
in functional brain networks in patients with early and
advanced PD (Nandhagopal et al., 2008; Lopes et al.,
2016; Tahmasian et al., 2017).
Here, we used a unilateral partial striatal 6-OHDA lesion
protocol producing 50% striatal DA depletion and in-
vestigated the functional brain network alterations in this
rat model of early-stage PD by subjecting the animals to
rsfMRI at 5 weeks after the 6-OHDA infusion. In particular,
we focused on analyzing different urethane-induced sleep-
like states (Clement et al., 2008; Wilson and Yan, 2010;
Pagliardini et al., 2013) and based on the RBD symptom-
atology, we hypothesized that the potential brain connectiv-
ity changes would becomemanifest during the REM state of
sleep. Furthermore, we measured the striatal levels of DA,
GABA, and glutamate, the key neurotransmitters controlling
the basal ganglia-thalamocortical motor network impaired in




The study was conducted in twenty 6-OHDA lesioned,
10 sham-operated, and 10 naïve male Wistar rats sup-
plied by the Laboratory Animal Center of the University of
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Eastern Finland (Kuopio, Finland). The rats were 8 weeks
old and weighed 270–360 g at the beginning of the ex-
periments. Unless otherwise stated, the rats were pair-
housed in stainless steel cages and kept on a 12 h
light/dark cycle (lights on at 07:00 A.M.) at an ambient
temperature of 22  1°C. Pelleted food (Teklad 2016S,
Harlan Laboratories) and tap water were available ad
libitum. All procedures were made in compliance with
ARRIVE guidelines and the European Commission Direc-
tive 2010/63/EU and were approved by the Finnish Na-
tional Animal Experiment Board (licenses ESAVI-2014-
701, ESAVI-2013-00833). All effort was taken to minimize
the number of animals used and their suffering.
Drugs
6-OHDA·HCl (Sigma-Aldrich) was dissolved in vehicle
(0.9% NaCl containing 0.2 mg/ml ascorbic acid). Pento-
barbital (Mebunat vet, Orion Oyj) and buprenorphine
(Schering-Plow) were dissolved in saline, and urethane
(Sigma-Aldrich) in sterile water. Lidocaine (Xylocaine) was
obtained from AstraZeneca. The doses of drugs refer to
the free bases.
Partial unilateral 6-OHDA lesion model of early-stage
PD
The rats were anesthetized with pentobarbital (55 mg/
kg, i.p.). Lidocaine was applied to the scalp and to the
surface of the skull and a single dose of buprenorphine
(0.02 mg/kg, s.c.) was given to relieve any postoperative
pain. Then, 6-OHDA (10 g/4 l, n  20) or vehicle (i.e.,
sham lesion, n  10) was infused into the right striatum
(coordinates from bregma: AP: 1.0, L: 2.7, DV: 5.0;
Paxinos and Watson, 2007) at a flow rate of 0.5 l/min.
The needle was retained in position for 4 min after the
infusion to prevent backflow. After the surgery, the ani-
mals were kept in individual stainless steel cages for 3 d
to allow recovery and subsequently returned in groups of
two. The success of the lesion was verified by striatal DA
analysis after rsfMRI imaging. Two animals were excluded
from the study based on an abnormal striatal DA ratio: (1)
no DA depletion was observed in lesioned striatum indi-
cating a failed 6-OHDA administration (lesion/intact DA
ratio 13	 SEM vs group mean), and (2) an abnormal
decrease in striatal DA ratio was observed in one sham
lesioned rat (lesion/intact DA ratio 6	 SEM vs group
mean). One 6-OHDA lesioned animal was excluded from
the study because of an abnormal finding in the anatomic
MRI image (possible cyst or effusion). Furthermore, one
sham lesioned animal was excluded from the biochemical
data analysis because of an error occurring during tissue
sample preparation.
fMRI
fMRI was done with 7T Bruker Pharmascan MRI system
(Bruker Biospin) 5 weeks after 6-OHDA or sham lesion
when the rats were 13 weeks old. Naïve animals were
imaged in the beginning of the experiments at 8 weeks of
age. A rat brain surface and a resonator volume coil were
used for signal reception and transmission, respectively
(both quadrature coils from Bruker Biospin). Rats were
anesthetized with urethane (1250–1500 mg/kg, i.p.), and
subsequently fixed to an MRI rat holder with ear bars and
a bite bar. The rsfMRI data were acquired with single-shot
spin-echo echoplanar imaging sequence with the follow-
ing parameters: repetition time: 2000 ms, echo time: 45
ms, 1200 volumes (40 min), field-of-view: 32 	 32 mm, 17
slices with a thickness of 0.9 mm, matrix size 64	 64, and
bandwidth 200 kHz.
An MRI-compatible small animal monitoring system
(Model 1025, Small Animal Instruments), including rectal
temperature probe, respiration pneumatic sensor, and
fiber-optic oximetry sensor, was used to monitor animal
physiology. The rats were kept warm (37°C) by a built-in
water circulation system (ThermoFisher Scientific).
Before the analyses, the rsfMRI data were converted to
NIfTI using in house written MATLAB code (http://aede-
s.uef.fi), slice-timing corrected, motion-corrected, spa-
tially smoothed (2 	 2 voxel full-width at half-maximum
Gaussian kernel), and coregistered by using SPM8 (www-
.fil.ion.ucl.ac.uk/spm) and MATLAB v2017b (MathWorks).
The FC analyses were done with an in-house MATLAB
code, Aedes, and SPM8. Seventeen regions-of-interest
(ROIs) were drawn according to an anatomic atlas (Paxi-
nos and Watson, 2007; Fig. 1). Subsequently, the rsfMRI
data were bandpass filtered at 0.01–0.08 Hz to minimize
physiologic and hardware-induced noise.
To obtain measures for FC, partial correlation coeffi-
cients between ROIs (or ROI and voxels in correlation
maps) were calculated by using MATLAB. All six motion
correction parameters, obtained with SPM, were used as
regressors in the correlation calculations to minimize the
effect of motion on the results.
Assessment of sleep states and FC
Fluctuations in breathing rate during fMRI were used as
indirect measures to detect spontaneous sleep-like states
as described by (Wilson et al., 2011; Pagliardini et al.,
2012). States with high and low breathing rates were
manually labeled as REM-like and non-REM (NREM)-like
sleep states, respectively. Animals with transitions be-
tween NREM-like and REM-like state were included in the
sleep-state analysis. The state-labeled fMRI data were
divided into windows of size of 30 volumes. State-labeled
partial correlation coefficients were calculated for each
window, and subsequently averaged within each subject.
If an animal did not have at least 90 fMRI volumes of
sleep-like state in total, it was excluded from the sleep-
state analysis.
Dissection of brain samples and biochemical
analyses
6-OHDA and sham lesioned animals were killed by
decapitation under urethane anesthesia immediately after
the rsfMRI measurements. After decapitation, the brains
were rapidly removed and both striata were dissected on
ice, frozen, and stored at 80°C until analyzed. The stri-
atal samples were homogenized (Soniprep 150 MSE Sci-
entific Instruments) in 25 volumes of ice-cold 0.1 M
perchloric acid (Merck KGaA). The homogenates were
centrifuged at 15000	 g (4°C, 15 min, Heraeus Sepatech,
Biofuge 17RS). The supernatant was collected and filtered
(GHP Acrodisc 13, 0.45 m) into Eppendorf tubes. Super-
New Research 3 of 12
January/February 2019, 6(1) e0456-18.2019 eNeuro.org
natants were further diluted twofold with 0.1 M perchloric
acid before DA analysis and 350-fold with acetonitrile
(CAN; Mallinckrodt Baker) before GABA and glutamate
analysis. DA levels in both striata were analyzed by a high
performance liquid chromatography method with electro-
chemical detection (Kääriäinen et al., 2008). Striatal GABA
and glutamate levels were measured with a liquid chro-
matography/mass spectrometry (LC-MS/MS) method.
Liquid chromatography was performed on Agilent 1290
Infinity LC (Agilent Technologies) instrumentation. GABA
and glutamate were separated using Waters Acquity
UPLC BEH amide column (100 	 2.1 mm, 1.7 m). The
column temperature was maintained at 40°C. The A mo-
bile phase was 40 mM ammonium formate buffer  ACN
(1:1) and the B mobile phase was 200 mM ammonium
formate buffer  ACN (1:10). A gradient was applied for
over 12 min as follows: from 0 to 6 min 95–70% B, from 6
to 7 min, 70–95% B, and finally the column was equili-
brated from 7 to 12 min at 95%. The flow rate was 0.3
ml/min and the injection volume was 5 l. The LC-MS/MS
data were acquired with an Agilent 6410 Triple Quadru-
pole Mass Spectrometer (Agilent Technologies) using
Multiple Reaction Monitoring applying the following con-
ditions: electrospray ionization, positive ion mode; drying
gas (nitrogen) temperature, 200°C; drying gas flow rate,
16 L/min; nebulizer pressure, 25 psi; and capillary voltage,
4500 V. Quantitative transitions were 104 ¡ 87 and 148
¡ 130 (m/z) for GABA and glutamate, respectively. The
fragmentor energy was 380 V and collision energy was 7
V for both GABA and glutamate. Biochemical analyses
were not performed on the naïve animals.
Striatal DA, GABA, and glutamate ratios were calcu-
lated with the equation Clesioned side/Cintact side.
Statistical analysis
All results are expressed as mean  SD. Differences in
DA, GABA, and glutamate levels in lesioned versus intact
striatum were tested with two-tailed paired t test using
GraphPad Prism 5.03 software. The physiologic parame-
ters were compared between groups using one-way
ANOVA with Tukey’s multiple-comparison test with
GraphPad Prism software. The comparison of sleep-like
states durations was done using two-tailed unpaired t test
with in-house MATLAB codes. The correlation coeffi-
cients were normalized with Fisher’s z-transformation.
The group comparison for ROI-based and seed-based
analysis were performed using two-tailed unpaired t test
with false discovery rate (FDR) correction for multiple
comparisons with in-house MATLAB codes. The criterion
for statistical significance was set at p  0.05 for all tests.
Results
The effect of the partial striatal 6-OHDA lesion on
striatal levels of dopamine, GABA, and glutamate
The effects of 6-OHDA and sham lesions on striatal
levels of biochemical markers are shown in Figure 2. As
expected, the partial striatal 6-OHDA lesion (n  18)
depleted striatal DA levels by 51% in the lesioned side
(33.2  10.5 vs 67.9  9.0 nmol/g of tissue weight in
lesioned and intact striatum, respectively; paired t test, p
 0.0001). Additionally, the 6-OHDA lesion induced a
slight but significant increase in striatal GABA levels
(23.1  2.0 vs 22.5  1.4 mol/g of tissue weight in le-
Figure 1 ROIs used for FC analysis. ROIs are overlaid on original spin-echo echoplanar imaging functional MRI images. AC, Auditory
cortex; CgC, cingulate cortex; HC, hippocampus; MC, motor cortex; mPFC, medial prefrontal cortex; RC, retrosplenial cortex; SC,
somatosensory cortex; Str, striatum; Th VL, ventral lateral thalamus; VC, visual cortex. Distance to bregma in millimeters is marked
in the top left corner of each slice.
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sioned and intact striatum, respectively; paired t test, p 
0.05). In contrast, the 6-OHDA lesion had no effect on
striatal glutamate levels (41.4  3.4 vs 42.2  3.5 mol/g
of tissue weight in lesioned and intact striatum, respec-
tively). The sham lesion (n  8) exerted no significant
effect on striatal DA (64.4  7.1 and 69.3  2.8 nmol/g of
tissue weight in sham-lesioned and intact striatum, re-
spectively, n.s.), GABA (22.7  1.3 vs 22.7  0.6 mol/g
of tissue weight in sham-lesioned and intact striatum,
respectively, n.s.) or glutamate (40.8  6.2 vs 41.7  4.2
mol/g of tissue weight in lesioned and intact striatum,
respectively, n.s.) levels.
Animal physiology during fMRI measurements
There were no statistical differences between the
6-OHDA and sham lesioned animals in any of the physi-
ologic measures [breathing rate (125  21 vs 128  19,
breaths/min, sham vs 6-OHDA, respectively), heart rate
(358 32 vs 380 37 beats/min), core body temperature
(37.1 0.4 vs 37.0 0.5°C), and weight (418 25 vs 412
 29 	 g)] during the onset of the fMRI measurement. In
the naïve group, the corresponding physiologic parame-
ters were as follows: breathing rate 107 12 breaths/min,
heart rate 349  39, temperature 36.7  0.6°C, and
weight 316  22 g, i.e. naïve animals had lower weights
and also a lower breathing rate than those of lesioned and
sham animals (both parameters p  0.05, one-way
ANOVA with Tukey’s test), but all parameters are within
the normal range.
The effects of the unilateral partial striatal 6-OHDA
lesion on overall connectivity
First, we investigated whether the sham lesion would
affect the FC by comparing the region–region connectivity
of the sham group to that of the naïve animals. Although
there were some weight and breathing differences be-
tween the sham and naïve animals, there were no differ-
ences in the resting-state FC (all p values  0.2, unpaired
t test, FDR-corrected; Fig. 3A), evidence of the robust-
ness of the urethane-induced REM/NREM-like FC states.
Because the sham lesion had no effect on the striatal
biochemical markers nor the resting-state FC, we com-
bined the naïve and sham groups and refer to it as the
control group (n  18) from here onward.
Next, we compared the resting-state FC obtained from
the whole fMRI measurement period between the
6-OHDA lesioned and control groups. This analysis re-
vealed no significant differences in FC between the
6-OHDA lesioned and control animals in overall connec-
tivity; only trends toward increased FC from the right to
the left ventral lateral thalamus (p  0.048, not FDR-
corrected) and from the right ventral lateral thalamus to
the cingulate cortex (p  0.040, not FDR-corrected) were
observed. In addition, there was a trend toward de-
creased FC from ipsilateral to contralateral striatum (p 
0.047, not FDR-corrected). After correction for multiple
comparisons, however, these trends become nonsignifi-
cant.
FC during different sleep states
The fact that REM sleep is more active and energy-
demanding state (Steriade and Hobson, 1976; Franzini,
1992; Lenzi et al., 2000) than NREM sleep and the prop-
osition that REM-sleep associated sleep disorders are
early symptoms of progressive neurodegeneration in PD
patients (Heller et al., 2017) prompted us to separate REM
and NREM sleep-like states in our rsfMRI analysis. Based
on the breathing rate fluctuations (Wilson et al., 2011), we
observed clear state changes between REM-like and
NREM-like state in 8/19 control animals and 8/18 lesion
animals. In the rest of the animals, only one sleep state
was observed, and they were excluded from the sleep-
state FC analysis. The lack of sleep-state transitions in
approximately one-half of the animals may be explained
by differences in the depth of anesthesia (Gretenkord
et al., 2016) or factors influencing respiratory function,
such as the environmental temperature (Whitten et al.,
2009) or inhaled oxygen (Pagliardini et al., 2013; Hauer
et al., 2018). The average durations for the REM-like and
NREM-like states were 99  80.4 and 78.6  70.8 s,
respectively. There were no significant differences in state
durations between control and 6-OHDA lesioned animals
(p  0.96 for REM-like states, p  0.84 for NREM-like
states, unpaired t test).
The FC differences between REM-like and NREM-like
states in the control group had the same pattern as
displayed by healthy rats in a previous study (Zhurakovs-
kaya et al., 2016): increased thalamocortical connectivity
Figure 2 Dopamine (nmol/g tissue), glutamate, and GABA levels (mol/g tissue) in the intact and lesioned striatum in 6-OHDA lesioned
and sham animals. Paired t test: p  0.05, p  0.001.
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Figure 3 FC between the brain regions in naïve and sham animals (A). There were no statistically significant differences after FDR correction for
multiple comparisons between sham and naïve groups. FC between the brain regions in 6-OHDA and control animals (B). Top, Connectivity
matrices for theREM-like state. Bottom,Connectivitymatrices for theNREM-like state. Left to right,Mean connectivitymatrix in 6-OHDA lesioned
animals, mean connectivity matrix in control animals, the difference between the first two panels. A higher absolute correlation coefficient
corresponds to higher connectivity between regions. In the difference pictures (top right), stars denote statistically significant differences between
groups (p  0.05, FDR-corrected for multiple comparisons). Abbreviations for brain regions as in Figure 1.
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during REM-like state and increased corticocortical con-
nectivity between hemispheres during the NREM-like
state. However, FC was disturbed in partially 6-OHDA
lesioned animals compared with control rats. Interest-
ingly, these disturbances were strongly dependent on
the sleep-like state (Fig. 3B). During the REM-like state,
corticocortical, striatocortical and corticohippocampal
connections were substantially decreased in 6-OHDA le-
sioned animals (p  0.05, FDR corrected; Figs. 3B, 4). In
contrast, during the NREM-like state, there were no dif-
ferences in the FC between the control and lesioned
animals (all p values  0.8).
The seed-based voxelwise analyses, obtained from ip-
silateral motor cortex and striatum (Fig. 5), illustrate the
6-OHDA-induced extensive striatocortical and subse-
quent corticocortical disruptions in FC during the REM-
like sleep state. No differences were observed during the
NREM-like state (data not shown).
Figure 4 Significantly decreased (p  0.05, FDR-corrected for multiple comparisons) connections between brain regions during
REM-like state in rats with partial striatal 6-OHDA lesion. The width of the line corresponds to the mean correlation difference between
control and lesioned groups: a thicker line represents a greater decrease in the correlation of the lesioned group. The differences in
correlation coefficients range from 0.12 to 0.41. Yellow lines represent p values from 0.01 to 0.05; red lines, p values  0.01.
Abbreviations for brain regions as in Figure 1.
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Discussion
Intrastriatal infusion of 6-OHDA produces a gradual
degeneration of the nigrostriatal dopaminergic pathway
and a partial DA depletion in the striatum accompanied
with behavioral manifestations resembling early-stage
PD. The behavioral outcomes of the partial 6-OHDA
model have been thoroughly characterized (Sauer and
Oertel, 1994; Przedbroski et al., 1995; Leikas et al., 2017),
and here, we show that the partial striatal DA depletion
induces sleep-state-dependent changes in FC between
several brain regions during urethane-induced sleep.
The observed DA deficiency (51%) 5 weeks after
infusion of a single 10 g intrastriatal 6-OHDA dose is well
in line with earlier studies using a similar 6-OHDA admin-
istration protocol (Lee et al., 1996; Leikas et al., 2017).
Importantly, the extent of the striatal DA depletion in the
present model is similar to that of the patients with an
early clinically detectable PD (Schapira, 2009), highlight-
ing the relevance of this model as an experimental model
of early PD. In addition, 6-OHDA induced a small but
significant increase in striatal GABA levels, which is in
accordance with earlier studies in experimental models of
PD (Tanaka et al., 1986; Chassain et al., 2008), as well as
with studies in PD patients using in vivo MRI (Emir et al.,
2012) or postmortem tissue level GABA analysis (Kish
et al., 1986). In contrast, the 6-OHDA lesion had no effect
on striatal GLU levels, which is consistent with an earlier in
vivo study conducted in 6-OHDA lesioned rats (Tanaka
et al., 1986), and parallels studies in PD patients (Taylor-
Robinson et al., 1999; Kickler et al., 2007).
Our initial rsfMRI analysis on overall FC, obtained from
the whole fMRI data, revealed only trends toward in-
creased connectivity in some thalamocortical connec-
tions and between the ipsilateral and contralateral
striatum. This result is in line with a very recent study in
partially 6-OHDA lesioned rats showing a modest in-
crease in FC in ipsi-lesioned and contra-lesioned regions
of the corticobasal ganglia network at 3 weeks after the
lesion (Perlbarg et al., 2018). The overall weaker changes
in connectivity strengths observed in our study are most
likely attributable to the smaller 6-OHDA dose (1 	 10 g
vs 2 	 10 g) resulting in a lower degree of nigrostriatal
dopaminergic damage in our model. In addition, a few
recent studies have shown FC changes occurring in rats
Figure 5 FC maps during REM-like state with seed region in right motor cortex (A) and right striatum (B). Top row, Group connectivity
map for lesioned animals (statistically different from 0 correlations, p  0.05, FDR-corrected for multiple comparisons); middle row,
group connectivity map for control animals; bottom row, statistically significant differences (p  0.05, FDR-corrected for multiple
comparisons) between the first two. The seed region is marked with arrows and circles in the group map of lesioned animals. Distance
to bregma for each slice is marked at the bottom.
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receiving higher 6-OHDA dose producing a complete loss
of striatal DA. As expected, the high degree of dopami-
nergic damage induced by an MFB lesion has more prom-
inent effects on FC, as indicated by reduced FC between
the striata and increased FC between the lesioned stria-
tum and cortical areas in both hemispheres (Monnot et al.,
2017), and by increased cross-hemispheric thalamic FC
and a general reduction in connectivity in the ipsilateral
hemisphere and especially in cortical areas (Westphal
et al., 2017). These clear differences between the partial
and full lesion models are most likely attributable to the
different degree of nigrostriatal dopaminergic damage.
Furthermore, more prominent compensatory mechanisms
in the MFB model may play a role in these phenomena.
These mechanisms include increased bursting activity of
the subthalamic nuclei (Janssen et al., 2012) and activa-
tion of alternative motor pathways (Eckert et al., 2006;
Mallol et al., 2007) that attempt to compensate for the
absence of ipsilateral nigrostriatal DA in the MFB model.
Altogether, the present study further supports the less
severe nature of the partial 6-OHDA lesion model and its
relevance as a model for early-stage PD.
The sleep disturbances associated with early PD stim-
ulated us to investigate whether the partial striatal
6-OHDA lesion rat model and urethane-induced sleep-like
states could be a relevant approach for studying the
pathophysiology of PD-related sleep disorders, particu-
larly RBD, which have been considered as an early marker
for PD because these sleep-related symptoms may ap-
pear even several years before the motor deficits (Pos-
tuma et al., 2013; Bargiotas et al., 2016). Sleep disorders
are also associated with altered brain FC (Ellmore et al.,
2013). Because natural sleep cannot be investigated with
preclinical rsfMRI, recent studies have exploited different
pharmacological tools to elicit sleep-like state (Wilson and
Yan, 2010; Zhurakovskaya et al., 2016). Urethane anes-
thesia can be considered a practical model of natural
sleep, because it is claimed to uniquely induce similar
EEG and respiratory characteristics and sleep-like states
as natural sleep in rodents. Additionally, urethane pro-
vides stable anesthesia for several hours with a normal
physiologic state as reflected in the normal values of
blood gases (Paasonen et al., 2016), while only minimally
modulating multiple neurotransmitter systems, several
brain regions, and autonomic functions (Maggi and Meli,
1986; Hara and Harris, 2002), making it an ideal anes-
thetic agent to be exploited in rsfMRI studies (Paasonen
et al., 2018). Furthermore, the connectivity differences
between states in urethane-anesthetized rats resemble
the changes in the connectivity patterns occurring in nat-
ural sleep in humans (Zhurakovskaya et al., 2016).
In the present study, the sleep-like state rsfMRI con-
nectivity patterns were similar in control animals as
previously described in healthy rats under urethane anes-
thesia (Zhurakovskaya et al., 2016), indicating that these
animals can serve as a valid control for detecting changes
in connectivity patterns. We found that brain FC patterns
differed between striatal 6-OHDA-lesioned and control
rats, but the differences between the groups were signif-
icant only during the REM-like sleep state. During the
REM-like sleep, the 6-OHDA lesion caused extensive dis-
turbances in FC in intracortical areas but also between
the cortical areas and the striatum and hippocampus.
Notably, reductions in FC occurred in both hemispheres
suggesting that the unilateral striatal DA depletion signif-
icantly also disturbed interhemispheric connections dur-
ing the REM-like sleep. The disruptions in striatocortical
signaling are not surprising considering the key role of
striatal DA in controlling the cortico-striato-thalamo-
cortical motor circuitry; according to this classical basal
ganglia circuitry model of PD, DA controls the release of
GABA in striatum, and thus regulates the activity of the
basal ganglia output nuclei. In PD, the striatal DA de-
pletion causes increased GABAergic inhibitory control
in thalamus leading to over-inhibition of the thalamo-
cortical glutamatergic signaling, and finally, to motor
dysfunction (Centonze et al., 1999; Blandini et al., 2000;
DeLong and Wichmann, 2007). In support for the do-
paminergic control of GABA release in striatum, we also
observed a slight increase in striatal GABA levels in
6-OHDA lesioned rats. The over-inhibition of the cor-
tico-striato-thalamo-cortical circuitry could be reflected
as reduced FC between the striatum and cortical areas.
One could also speculate that the observed intracorti-
cal disruptions are a downstream consequence of the
impaired striatocortical signaling.
It is noteworthy that we did not observe any significant
6-OHDA lesion-dependent changes in FC without differ-
entiating between the different sleep-like states. Thus, it
appears that the categorization of data based on sleep-
like states improves the sensitivity of the rsfMRI analysis.
The presence of the significantly impaired striatocortical
connectivity only during the REM-like state could be ex-
plained by an overall decrease in cortical effective con-
nectivity during the NREM-like state, which is partially
restored during the REM-like state (Massimini et al.,
2010). In other words, the silencing of long-range connec-
tivity from cortex during the NREM state might hinder the
observation of striatocortical connectivity changes. How-
ever, this explanation does not apply to the changes in
corticocortical connectivity. Another possibility for the al-
tered FC during different states of sleep is the direct partic-
ipation of DA in the regulation of sleep. Striatal 6-OHDA
injections induce retrograde dopaminergic cell death in sub-
stantia nigra pars compacta (Penttinen et al., 2016), and it is
well established that a loss of these neurons disturbs the
sleep patterns of rats (Lima et al., 2007), including changes
in the regulation of muscle tone during REM sleep (Vo et al.,
2014). This may be reflected in alterations in the connectivity
between motor and somatosensory cortex and other corti-
cal areas, as well as striatocortical connectivity during
urethane-induced sleep.
It is interesting to note that the 6-OHDA-induced
changes in FC were not restricted to the classical PD-
associated cortico-striato-thalamo-cortical circuitry during
the REM-like sleep. In particular, ipsilateral and contralat-
eral hippocampal connections with the striatum, the cin-
gulate cortex, and the ventral lateral thalamus were
impaired by the striatal DA depletion. The disturbances in
hippocampal connections may be associated with the
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well established memory impairing effects of the 6-OHDA
lesion (More et al., 2016). It is unclear how striatal DA loss
regulates hippocampal connections because there is no
direct pathway connecting the dorsal striatum and hip-
pocampus. However, FC may occur between any brain
structures that are connected by large distributed net-
works. For instance, thalamus plays a central role in the
complex network connecting the basal ganglia and corti-
cal areas (Lanciego et al., 2012), and the hippocampus
receives inputs from the thalamus. These excitatory in-
puts may well be affected by the increased GABAergic
inhibitory control from the basal ganglia and explain the
decreased hippocampal connectivity in 6-OHDA rats. Fur-
thermore, the hippocampus has direct connections to the
association cortex and to the entorhinal cortex, which has
reciprocal projections to the cingulate cortex (Kerr et al.,
2007). The cingulate cortex is further connected to wide
cortical areas, and through this pathway, the hippocam-
pus is also connected to many cortical areas. Therefore, it
can be hypothesized that altered striatocortical connec-
tivity could trigger disruptions in the balance of intracor-
tical FC, which could be reflected as disturbances in
corticohippocampal connectivity.
Non-invasive imaging and FC analysis are effective
tools in the comparison of animal disease models and
human pathology. In our study, the corticocortical and
striatocortical connectivities were significantly decreased
in 6-OHDA-lesioned animals during the REM-like sleep
state. Decreased connectivity within the basal ganglia
circuitry has been detected in patients with early stage PD
(Szewczyk-Krolikowski et al., 2014; Dayan and Browner,
2017). Furthermore, the decreased FC from putamen to
sensorimotor cortex and contralateral putamen has been
observed already in an early stage of the disease (Luo
et al., 2014). In patients with mid-stage and advanced
stage of PD, decreased corticocortical and striatocortical
connectivity has been reported in several studies (Hacker
et al., 2012; Sharman et al., 2013). However, to confirm
the translational value of the present results, the imaging
should be conducted in conscious 6-OHDA lesioned an-
imals. In addition, there is always variability in clinical
studies in patients’ disease severities, pharmacothera-
pies, and ages, which introduces uncontrollable disper-
sion to data and complicates the comparison between
animal studies and clinical findings. Despite the obvious
differences between species and challenges in data ac-
quisition in rodent rsfMRI compared with human studies,
intrastriatally administered 6-OHDA, i.e., producing 50%
striatal DA depletion, appears to induce the FC changes
resembling those present in PD patients. Hence, these find-
ings improve the construct validity of the partial striatal
6-OHDA lesion model.
Rodents with various nigrostriatal 6-OHDA lesions have
been reported to display similar disturbances in sleep
architecture as observed in PD patients. For example, rats
with unilateral MFB lesion encounter increased muscle
activity and limb movements during REM sleep (Vo et al.,
2014) resembling those in PD patients. Furthermore, rats
with bilateral partial striatal 6-OHDA lesion spend more
time awake and have more frequent sleep-state transi-
tions that induce limb movements and trigger arousals
from sleep (Decker et al., 2000). In addition, bilaterally
administered intrastriatal 6-OHDA disrupts endogenous
circadian rhythm in mice (Masini et al., 2017). Altogether,
these behavioral findings further support the applicability
of nigrostriatal 6-OHDA lesion in modeling PD-related
sleep disorders.
In conclusion, this study shows that the partial unilateral
striatal 6-OHDA lesion altered brain FC patterns when rats
were in a urethane-induced REM-like sleep state. There-
fore, the present model can serve as a valid tool to
investigate the REM-sleep associated disorders charac-
teristic of early PD.
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